CONTEXT: Primary vesicoureteral reflux (VUR) is a common congenital urinary tract
abnormality in children. There is considerable controversy regarding its management …

The treatment of vesicoureteral reflux (VUR) has evolved over the past half-century from
primarily surgical to nonoperative treatments in most cases [1, 2]. Although the benefits of …

Purpose: To report on a novel technique of endoscopic intravesical ureteral mobilization and
cross-trigonal ureteral reimplantation under carbon dioxide insufflation of the bladder …

Purpose: Emerging data demonstrate that injection of dextranomer/hyaluronic acid (Dx/HA)
copolymer (Deflux, Q-Med Scandinavia, Uppsala, Sweden) is a safe and effective treatment …

Purpose: Endoscopic subureteral injection of tissue augmenting substances has become an
established alternative to long-term antibiotic prophylaxis and open surgery for the …

PURPOSE: Subureteral injection of dextranomer/hyaluronic acid copolymer is widely
accepted for the treatment of primary vesicoureteral reflux. Few studies document the …

Purpose: Previous approaches to the endoscopic correction of vesicoureteral reflux have
used foreign bulking substances, raising concern regarding safety and long-term efficacy …

Purpose: During the last 20 years endoscopic treatment of vesicoureteral reflux (VUR) has
gained popularity in European countries. We performed a retrospective analysis of our 17 …

PURPOSE: We review our 17-experience with endoscopic subureteral
polytetrafluoroethylene injection for the treatment of primary vesicoureteral reflux in children …

Objective To evaluate an outcome of endoscopic correction of vesicoureteral reflux (VUR)
using Vantris (Promedon, Cordoba, Argentina) in terms of its effectiveness and morbidity in a …